Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

0

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On December7, 2017, the Company issued a press release announcing the retirement of Mr.Cajigas as Executive Vice President, Chief Financial Officer and Treasurer and the anticipated appointment of Ms.Vosseller as Chief Financial Officer. A copy of the press release is attached hereto as Exhibit99.1. The press release is being furnished with this Current Report and shall not be deemed “filed” for the purposes of Section18 of the Securities and Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except as expressly set forth by specific reference in such filing.

Item 5.02. Financial Statements and Exhibits.

(d) Exhibits.


TANDEM DIABETES CARE INC Exhibit
EX-99.1 2 d503383dex991.htm EX-99.1 EX-99.1 Exhibit 99.1           Media Contact: Steve Sabicer 714-907-6264 [email protected]       Investor Contact: Susan Morrison 858-366-6900 x7005 [email protected] FOR IMMEDIATE RELEASE Tandem Diabetes Care Announces Retirement of CFO and Successor Appointment San Diego,…
To view the full exhibit click here

About Tandem Diabetes Care, Inc. (NASDAQ:TNDM)

Tandem Diabetes Care, Inc. is a medical device company. The Company is engaged in designing, developing and commercializing products for people with insulin-dependent diabetes. The Company manufactures and sells three insulin pump products, which include t:slim Insulin Delivery System (t:slim), t:flex Insulin Delivery System (t:flex) and t:slim G4 Insulin Delivery System (t:slim G4). Its technology platform features Micro-Delivery Technology, a miniaturized pumping mechanism, which draws insulin from a flexible bag within the pump’s cartridge rather than relying on a syringe and plunger mechanism. It also features a software, which is a vivid color touch screen and a micro- universal serial bus (USB) connection that supports both a rechargeable battery and uploads to t:connect Diabetes Management Application (t:connect), its custom cloud-based data management application that provides display therapy management data from the pump and supported blood glucose meters.

An ad to help with our costs